Cargando…
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Owing to its easy-to-use and multiplexing nature, the genome editing tool CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats (CRISPR) associated nuclease 9) is revolutionizing many areas of medical research and one of the most amazing areas is its gene therapy potentials. Previou...
Autores principales: | Dai, Wei-Jing, Zhu, Li-Yao, Yan, Zhong-Yi, Xu, Yong, Wang, Qi-Long, Lu, Xiao-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023403/ https://www.ncbi.nlm.nih.gov/pubmed/28131272 http://dx.doi.org/10.1038/mtna.2016.58 |
Ejemplares similares
-
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020) -
Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do
por: Yin, Tao
Publicado: (2021) -
Ethical implications of fighting malaria with CRISPR/Cas9
por: Patrão Neves, Maria, et al.
Publicado: (2017) -
Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016) -
New hurdles for translational research
por: Dowsett, Mitch
Publicado: (2000)